531
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Risk Factors for Poor Quality of Life among Patients with Age-Related Macular Degeneration

, , , &
Pages 772-780 | Received 30 Jan 2016, Accepted 15 Apr 2016, Published online: 10 Aug 2016

REFERENCES

  • Stein J, Brown MM, Brown GC, Hollands H, Sharma S. Quality of life with macular degeneration: Perceptions of patients, clinicians, and community members. Br J Ophthalmol 2003;87:8–12.
  • Synek S, Vojniković B, Pahor D. Epidemiology and quality of life of patients with age-related macular degeneration. Coll Antropol 2010;34:25–28.
  • Seddon JM, Sharma S, Adelman RA. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 2006;113:260–266.
  • Kanagasingam Y, Bhuiyan A, Abràmoff MD, Smith RT, Goldschmidt L, Wong TY. Progress on retinal image analysis for age related macular degeneration. Prog Retin Eye Res 2014;38:20–42.
  • Dawson SR, Mallen CD, Gouldstone MB, Yarham R, Mansell G. The prevalence of anxiety and depression in people with age-related macular degeneration: A systematic review of observational study data. BMC Ophthalmol 2014;14:78.
  • Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514–520.
  • Chung SD, Ho JD, Hwa P, Lee HC, Lin HC. Increased risk of depressive disorder following a diagnosis of neovascular age-related macular degeneration. Acta Ophthalmol 2015;93:176–177.
  • Rovner BW, Casten RJ, Massof RW, Leiby BE, Tasman WS; Wills Eye AMD Study. Psychological and cognitive determinants of vision function in age-related macular degeneration. Arch Ophthalmol 2011;129:885–890.
  • Finger RP, Fleckenstein M, Holz FG, Scholl HP. Quality of life in age-related macular degeneration: A review of available vision-specific psychometric tools. Qual Life Res 2008;17:559–574.
  • Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050–1058.
  • Chatziralli IP, Sergentanis TN, Peponis VG, Papazisis LE, Moschos MM. Risk factors for poor vision-related quality of life among cataract patients: Evaluation of baseline data. Graefes Arch Clin Exp Ophthalmol 2013;251:783–789.
  • Yuzawa M, Fujita K, Tanaka E, Wang EC. Assessing quality of life in the treatment of patients with age-related macular degeneration: Clinical research findings and recommendations for clinical practice. Clin Ophthalmol 2013;7:1325–1332.
  • Cahill MT, Banks AD, Stinnett SS, Toth CA. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 2005;112:152–158.
  • Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997;115:777–784.
  • Turkoglu EB, Celık E, Aksoy N, Bursalı O, Ucak T, Alagoz G. Changes in vision related quality of life in patients with diabetic macular edema: Ranibizumab or laser treatment? J Diab Compl 2015;29:540–543.
  • Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S. Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Br J Ophthalmol 2010;94:319–323.
  • Aydin Kurna S, Altun A, Gencaga T, Akkaya S, Sengor T. Vision related quality of life in patients with keratoconus. J Ophthalmol 2014;2014:694542.
  • Le Q, Zhou X, Ge L, Wu L, Hong J, Xu J. Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population. BMC Ophthalmol 2014;12:22.
  • Ware JE. SF-36 Physical and Mental Health Summary Scales: A User’s Manual; Boston: The Health Institute, New England Medical Center, 1994.
  • Au Eong KG, Chan EW, Luo N, et al. Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population. Eye 2012;26:379–388.
  • Fuhs A, Dasch B, Behrens T, et al. Visual function and quality of life in patients with age-related maculopathy: Results of the Münster Age and Retina Study (MARS). Klin Monbl Augenheilkd 2005;222:649–654.
  • Leys A, Zlateva G, Shah SN, Patel M. Quality of life in patients with age-related macular degeneration: Results from the VISION study. Eye 2008;22:792–798.
  • Slakter JS, Stur M. Quality of life in patients with age-related macular degeneration: Impact of the condition and benefits of treatment. Surv Ophthalmol 2005;50:263–273.
  • Magnione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ): NEI-VFQ Field Test Investigators. Arch Ophthalmol 1998;116:1496–1504.
  • Laboratory of Experimental Ophthalmology of Aristotle University, Thessaloniki, Greece, 2000. http://www.rand.org/content/dam/rand/www/external/health/surveys_tools/vfq/vfq25survey_greek.pdf (accessed on June 20, 2015).
  • Labiris G, Katsanos A, Fanariotis M, et al. Psychometric properties of the Greek version of the NEI-VFQ 25. BMC Ophthalmol 2008;8:4.
  • Kontodimopoulos N, Pappa E, Niakas D, Yfantopoulos J, Dimitrakaki C, Tountas Y. Validity of the EuroQoL (EQ-5D) instrument in a Greek general population. Value Health 2008;11:1162–1169.
  • Kay S, Ferreira A. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. Ophthalmic Epidemiol 2014;21:66–78.
  • Pappa E, Kontodimopoulos N, Niakas D. Validating and norming of the Greek SF-36 Health Survey. Qual Life Res 2005;14:1433–1438.
  • Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 1999;128:45–53.
  • Childs AL; Submacular Surgery Trials Patient-Centered Outcomes Subcommittee for the Submacular Surgery Trials Pilot Study Investigators. Responsiveness of the SF-36 health survey to changes in visual acuity among patients with subfoveal choroidal neovascularization. Am J Ophthalmol 2004;137:373–375.
  • Cavar I, Lovrić S, Vukojević M, Sesar I, Petric-Vicković I, Sesar A. Metabolic risk factors, coping with stress, and psychological well-being in patients with age-related macular degeneration. Acta Clin Croat 2014;53:79–87.
  • Gautam P, Shrestha JK, Joshi SN. The factors associated with age related macular degeneration and quality of life of the patients in a tertiary-level ophthalmic center in Kathmandu. Nepal J Ophthalmol 2009;1:114–117.
  • Sahel JA, Bandello F, Augustin A, Maurel F, Negrini C, Berdeaux GH; MICMAC Study Group. Health-related quality of life and utility in patients with age-related macular degeneration. Arch Ophthalmol 2007;125:945–951.
  • Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001;108:1893–1900.
  • Pesudovs K, Gothwal VK, Wright T, Lamoureux EL. Remediating serious flaws in the National Eye Institute Visual Function Questionnaire. J Cataract Refract Surg 2010;36:718–732.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.